Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Karaca

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|April 25, 2016
Conformational, electronic, and spectroscopic characterization of isophthalic acid (monomer and dimer structures) experimentally and by DFTF Bardak, C Karaca, S Bilgili, et al.
International Journal of Clinical Practice|August 18, 2004
Efficacy of alpha interferon therapy for lamivudine resistance in chronic hepatitis BA Danalioglu, S Kaymakoglu, Y Cakaloglu, et al.
Waste Management (New York, N.Y.)|June 29, 2014
Scientific basis of dissolved organic carbon limitation for landfilling of municipal treatment sludge--is it attainable and justifiable?S Sözen, E Ubay Cokgor, G Insel, et al.
Acta Gastro-Enterologica Belgica|January 16, 2019
Should we worry about incidental gastrointestinal tract involvement in positron emission tomography/computed tomography as gastroenterologist?R Iliaz, B Cavus, G Yegen, et al.
Hepato-Gastroenterology|July 13, 2004
Crohn's disease; analysis of 105 patientsS Ozdil, K Demir, G Boztas, et al.
European Review for Medical and Pharmacological Sciences|May 24, 2016
Can Helicobacter pylori be eradicated with high-dose proton pump inhibitor in extensive metabolizers with the CYP2C19 genotypic polymorphism?A Ormeci, Z Emrence, B Baran, et al.
World Journal of Gastroenterology|October 17, 2003
Adrenomedullin in cirrhotic and non-cirrhotic portal hypertensionV Tahan, E Avsar, C Karaca, et al.
European Review for Medical and Pharmacological Sciences|March 25, 2016
Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazoleA Ormeci, Z Emrence, B Baran, et al.
Journal of Viral Hepatitis|January 4, 2014
Treatment failure may lead to accelerated fibrosis progression in patients with chronic hepatitis CB Baran, M Gulluoglu, O M Soyer, et al.
European Review for Medical and Pharmacological Sciences|March 25, 2016
Steroid-refractory inflammatory bowel disease is a risk factor for CMV infectionA C Ormeci, F Akyuz, B Baran, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|April 25, 2016
Conformational, electronic, and spectroscopic characterization of isophthalic acid (monomer and dimer structures) experimentally and by DFTF Bardak, C Karaca, S Bilgili, et al.
International Journal of Clinical Practice|August 18, 2004
Efficacy of alpha interferon therapy for lamivudine resistance in chronic hepatitis BA Danalioglu, S Kaymakoglu, Y Cakaloglu, et al.
Waste Management (New York, N.Y.)|June 29, 2014
Scientific basis of dissolved organic carbon limitation for landfilling of municipal treatment sludge--is it attainable and justifiable?S Sözen, E Ubay Cokgor, G Insel, et al.
Acta Gastro-Enterologica Belgica|January 16, 2019
Should we worry about incidental gastrointestinal tract involvement in positron emission tomography/computed tomography as gastroenterologist?R Iliaz, B Cavus, G Yegen, et al.
Hepato-Gastroenterology|July 13, 2004
Crohn's disease; analysis of 105 patientsS Ozdil, K Demir, G Boztas, et al.
European Review for Medical and Pharmacological Sciences|May 24, 2016
Can Helicobacter pylori be eradicated with high-dose proton pump inhibitor in extensive metabolizers with the CYP2C19 genotypic polymorphism?A Ormeci, Z Emrence, B Baran, et al.
World Journal of Gastroenterology|October 17, 2003
Adrenomedullin in cirrhotic and non-cirrhotic portal hypertensionV Tahan, E Avsar, C Karaca, et al.
European Review for Medical and Pharmacological Sciences|March 25, 2016
Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazoleA Ormeci, Z Emrence, B Baran, et al.
Journal of Viral Hepatitis|January 4, 2014
Treatment failure may lead to accelerated fibrosis progression in patients with chronic hepatitis CB Baran, M Gulluoglu, O M Soyer, et al.
European Review for Medical and Pharmacological Sciences|March 25, 2016
Steroid-refractory inflammatory bowel disease is a risk factor for CMV infectionA C Ormeci, F Akyuz, B Baran, et al.
Pageof 5